Article Details
Retrieved on: 2019-11-14 07:03:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Zynerba Pharmaceuticals (NASDAQ:ZYNE) issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.44) EPS ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here